

Sales (800) 266-7207 EXT 700 | Direct (424) 444-7184

  • GOVERNMENT BUYER
  • CLINICIAN SIGN UP
Work with Us
Pre-IPO Investment
  • Home
  • About Us
    • Our Team
    • Mission & Values
    • Tribal Activism in Public Policy
    • Commitment to Quality & Compliance
    • Partnerships with Clinicians & Healthcare Providers
  • Products
    • All Products
    • Amniotic Tissue Grafts
      • RAMPART (2 Layers)
    • Wound Care Pre-Graft
  • Clinical Resources
    • Clinical Case Studies
    • Clinician Sign Up
  • News
  • For Patients
    • Amniotic Skin Grafts FAQs
  • Account Sign Up
  • Home
  • About Us
    • Our Team
    • Mission & Values
    • Commitment to Quality & Compliance
    • Partnerships with Clinicians & Healthcare Providers
    • Tribal Activism in Public Policy
  • Products
  • Amniotic Skin Grafts FAQs
  • Clinical Case Studies
  • News
  • Government Buyer
  • Opportunities
    • Pre-IPO Investment
    • Work With Us

Tribal Consortium Files 910-Page Substantive Comment on CY 2026 Medicare Physician Fee Schedule Proposed Rule

Jul 16, 2025 | News

The Tribal Biotechnology & Health Consortium today filed a 910-page substantive comment with the Centers for Medicare & Medicaid Services on the proposed CY 2026 Medicare Physician Fee Schedule. The filing, docketed at Regulations.gov as Comment ID...

Clear Health Pass and CMS Coverage Group Convene Working Session on ASP and HCPCS Code Integrity for Q4347

Jun 12, 2025 | News

The Tribal Consortium’s Authorized Tribal Agent, Clear Health Pass Holdings, joined a working session with CMS Drug Pricing and the Coverage and Analysis Group to address the Average Sales Price submission and HCPCS code record for Rampart™ DL Matrix (Q4347)....

CMS Convenes Tribal Consultative Meeting on Rampart™ DL Matrix with Clear Health Pass and the Division of Tribal Affairs

May 22, 2025 | News

The Centers for Medicare & Medicaid Services convened a formal Tribal Consultative Meeting with Clear Health Pass Holdings, Authorized Tribal Agent for the Tribal Biotechnology & Health Consortium, to review the federal coverage and reimbursement framework for...

Clear Health Pass Holdings Acquires Exclusive Worldwide Rights to Rampart™ DL Matrix as Authorized Tribal Agent

Jan 21, 2025 | News

Clear Health Pass Holdings, LLC today completed its acquisition of exclusive worldwide commercial rights, administrative authority, and HCPCS Q-code holder responsibilities for Rampart™ DL Matrix (Q4347), the FDA-cleared advanced wound care matrix used by...

Clear Health Pass Wound Care Partners with Tribal Leaders to Combat Diabetes Crisis in Native American Communities

Oct 18, 2024 | News, Press Release, Study

Hollywood, FL – October 18, 2024 – Clear Health Pass Wound Care (CHP WC), in collaboration with a consortium of tribal leaders, is launching a comprehensive initiative to address the growing diabetes-related health crisis within Native American populations—a crisis...

Clear Health Pass Presents Tribal Sovereign Framework to CMS and Novitas Solutions Policy Team

Jun 24, 2024 | News

The Tribal Consortium, represented by Clear Health Pass Holdings, joined Centers for Medicare & Medicaid Services policy leadership and Novitas Solutions — the Medicare Administrative Contractor authoring the Local Coverage Determination for skin substitute...
« Older Entries
Next Entries »


Join Our

Newsletter

Clear Health Pass™ Clear Health Pass Holdings, LLC (“CHP”) serves as an authorized Tribal Agent for a multi-tribal economic development and sovereign innovation initiative, pursuant to written delegations issued by federally recognized Tribal economic development corporations organized under Section 16 / Section 17 of the Indian Reorganization Act (25 U.S.C. sections 5123-5124).

Quick Resources

Work with Us
Pre-IPO Investment

Setup Your Account Today

  • GOVERNMENT BUYER
  • CLINICIAN SIGN UP

 Call Us

Sales (800) 266-7207 EXT 700
Direct (424) 444-7184

Clear Health Pass Wound Care © copyright 2024 All Rights Reserved

  • Sitemap
  • Terms and Conditions